Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Circulation Research
|
January 1, 1990
Bradykinin contribution to renal blood flow effect of angiotensin converting enzyme inhibitor in the conscious sodium-restricted dog
B G Zimmerman, P C Raich, R J Vavrek, et al.
Cancer
|
October 15, 1982
Lymphomatoid granulomatosis and Epstein-Barr virus
R W Veltri, P C Raich, J E McClung, et al.
Nature
|
July 20, 1978
Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells
J M Zarling, H I Robins, P C Raich, et al.
The New England Journal of Medicine
|
August 24, 1972
Androgen-induced increase in red-cell 2,3-diphosphoglycerate
J P Parker, G J Beirne, J N Desai, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
January 1, 1997
Perception of preventive health needs in a prostate-cancer screening population: a preliminary report
P C Raich, M A Zoeter, M Hagan, et al.
Cancer Treatment Reports
|
September 1, 1982
Phase II study of vindesine in patients with advanced breast cancer
B K Walker, P C Raich, J Fontana, et al.
Cancer Treatment Reports
|
May 1, 1983
Combination of vindesine and prednisone in malignant lymphoma and acute leukemia
P C Raich, B K Walker, J S Rogers, et al.
Cancer Treatment Reports
|
January 1, 1983
Cancer and leukemia group B phase II non-small cell lung carcinoma trial: aziridinylbenzoquinone (AZQ)
R W Carey, R L Comis, D Anbar, et al.
The West Virginia Medical Journal
|
August 11, 1991
IL-2/LAK cell treatment for advanced cancers with emphasis on a novel administration
M L Auber, J I DeHaven, P C Raich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1987
Chemohormonal therapy in advanced carcinoma of the breast: Cancer and Leukemia Group B protocol 8081
M C Perry, C G Kardinal, A H Korzun, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Circulation Research
|
January 1, 1990
Bradykinin contribution to renal blood flow effect of angiotensin converting enzyme inhibitor in the conscious sodium-restricted dog
B G Zimmerman, P C Raich, R J Vavrek, et al.
Cancer
|
October 15, 1982
Lymphomatoid granulomatosis and Epstein-Barr virus
R W Veltri, P C Raich, J E McClung, et al.
Nature
|
July 20, 1978
Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells
J M Zarling, H I Robins, P C Raich, et al.
The New England Journal of Medicine
|
August 24, 1972
Androgen-induced increase in red-cell 2,3-diphosphoglycerate
J P Parker, G J Beirne, J N Desai, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
January 1, 1997
Perception of preventive health needs in a prostate-cancer screening population: a preliminary report
P C Raich, M A Zoeter, M Hagan, et al.
Cancer Treatment Reports
|
September 1, 1982
Phase II study of vindesine in patients with advanced breast cancer
B K Walker, P C Raich, J Fontana, et al.
Cancer Treatment Reports
|
May 1, 1983
Combination of vindesine and prednisone in malignant lymphoma and acute leukemia
P C Raich, B K Walker, J S Rogers, et al.
Cancer Treatment Reports
|
January 1, 1983
Cancer and leukemia group B phase II non-small cell lung carcinoma trial: aziridinylbenzoquinone (AZQ)
R W Carey, R L Comis, D Anbar, et al.
The West Virginia Medical Journal
|
August 11, 1991
IL-2/LAK cell treatment for advanced cancers with emphasis on a novel administration
M L Auber, J I DeHaven, P C Raich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1987
Chemohormonal therapy in advanced carcinoma of the breast: Cancer and Leukemia Group B protocol 8081
M C Perry, C G Kardinal, A H Korzun, et al.
Page
of 6